English | Español

Technology/Innovation
+ Technology/Innovation
Patient Daily | May 24, 2023

Lilly's peresolimab Phase 2a rheumatoid arthritis trial published in The New England Journal of Medicine
+ Technology/Innovation
Patient Daily Report | May 24, 2023

Arun Sharma: 'If we can leverage microgravity to grow more stem cells than we could on Earth, that could be a huge benefit for patient care'
+ Technology/Innovation
Patient Daily Report | May 23, 2023

Dr. Janet Maynard: new FDA-approved drug will 'provide an additional safe and effective option for women' experiencing hot flashes
+ Technology/Innovation
Patient Daily | May 22, 2023

Vizzia Technologies Achieves SOC 2 Type II Compliance Certification for RTLS
+ Technology/Innovation
Pacient Daily | May 22, 2023

Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa
+ Technology/Innovation
Pacient Daily | May 22, 2023

Clinical ink Work Demonstrating Technology Sensitivity to Parkinson’s Disease Published in Nature
+ Technology/Innovation
Patient Daily | May 22, 2023

Loxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting
+ Technology/Innovation
Pacient Daily | May 18, 2023

How OR Automation Keeps Surgeons Busy (and Revenues Up)

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes